Stay updated on EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page
- Check4 days agoChange DetectedThe new screenshot shows minor UI adjustments and reorganization; core study details, eligibility criteria, and outcome measures appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check32 days agoChange DetectedPage now shows version v3.2.0 and a government-operating-status notice; old version v3.1.0 is removed.SummaryDifference5%

- Check40 days agoChange DetectedUpdated the page from version v3.0.2 to v3.1.0, reflecting a new software/document version.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has undergone significant changes, including the removal of specific location details and the deletion of certain medical conditions, while also adding a facility name and a new version revision.SummaryDifference3%

Stay in the know with updates to EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EA-2353 Dose Escalation in Retinitis Pigmentosa Clinical Trial page.